Quick Summary:
In the rapidly evolving healthcare sector, the global orthobiologics devices and equipment market presents a mix of opportunities and challenges. The accelerating demand for advanced treatment methods for musculoskeletal disorders, combined with an aging global population, has spurred significant growth within the industry.
Our comprehensive market research report provides vital insight into this dynamic market, offering a deep understanding of the key trends, potential challenges and emerging opportunities. From demineralized bone matrix to stem cell therapy, the report covers the broad range of orthobiologic devices and their applications in orthopedic clinics, hospitals and other healthcare facilities.
Rise above uncertainties in the changing landscape with our report. Armed with this knowledge, you'll be well-positioned to make strategic decisions that can propel your business forward. Our report outlines the major players in the market, thus offering an overview of the competitive landscape. Gain the advantage in the orthobiologics devices and equipment market by gaining invaluable insights offered in this market research report.
The global orthobiologics devices and equipment market will grow from $3.69 billion in 2021 to $4.01 billion in 2022 at a compound annual growth rate (CAGR) of 8.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The orthobiologics devices and equipmen market is expected to grow to $4.82 billion in 2026 at a CAGR of 4.7%.
The orthrobiologic devices market consists of sales of demineralized bone matrix, synthetic bone substitutes, stem cell therapy, plasma-rich protein, viscosupplementation, bone morphogenetic protein, and other synthetic orthobiologics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
Orthrobiologic devices are implants composed of cells and proteins that are naturally found in the human body which provide accelerated healing by stimulating efficient regrowth of musculoskeletal tissues including bones, cartilage, tendons, and ligaments.
North America was the largest region in the orthobiologics devices and equipment market in 2022. Western Europe was the second-largest region in the orthobiologics devices and equipment market. The regions covered in orthobiologics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The main product types of orthobiologics devices and equipment are demineralized bone matrix, synthetic bone substitutes, stem cell therapy, plasma-rich protein, viscosupplementation, bone morphogenetic protein, and synthetic orthobiologics. Stem cell therapy is promoting the repair response of diseased, dysfunctional, or injured tissue using stem cells or their derivatives. The various applications involved are osteoarthritis and degenerative arthritis, soft-tissue injuries, fracture recovery, maxillofacial and dental applications, spinal fusion, trauma repair, and reconstructive surgery that are used by various end-users such as hospitals, orthopedic clinics, others.
The aging population profile of most countries contributed to the growth of orthobiologics devices and equipment market globally. According to the United Nations report, there were 962 million people aged over 60 across the globe, comprising 13% of the global population. The population aged over 60 is expected to grow at a rate of about 3% every year. The report further estimated that Europe had the highest percentage of the population aged over 60. The number of people globally over the age of 65 grew by 33%, according to estimates based on Population Reference Bureau data. The increase in the aging population has increased the patient pool of many orthopedic disorders and led to an increase in the demand for orthobiologics devices and equipment market.
Rising incidences of post-surgical complications in patients implanted with orthobiologics devices are one of the major restraints in the orthobiologics devices and equipment market. Surgical procedures with orthobiologics grafts, implants, and devices have become increasingly common in recent years. Major postoperative complications include device failures, bleeding, postoperative infections, immune responses, and rejections. These procedures may develop post-surgery complications which refer to the development of any unwanted or unexpected conditions related to the device, graft, or implant. These complications may vary with the type of procedure, implant, graft, or device, the experience of the surgeon, improper device testing procedures before market launch, device location in the body, and the health and biological response of the individual. The increasing post-operative complications and device failures can limit the orthobiologics devices and equipment market.
Biodegradable implants are increasingly being used in orthobiologics treatment and trauma orthopedic surgeries. Biodegradable implants are used to replace a missing biological structure, support a damaged biological structure, and enhance the existing bone structure. Biodegradable products such as re-absorbable polymers composed of polyglycolic acid and polylactic acid manufactured in the form of plates, screws, and pins are replacing traditional devices like plates and screws which are more expensive. Surgeons are preferring biodegradable implants to replace conventional implants, as biodegradable implants can be engineered to provide temporary support for bone fractures, can degrade at a rate matching new tissue formation, eliminate the need for the second surgery, and are highly useful in fracture fixation in children with less implant-related infections. For instance, Stryker Corp. offers orthobiologics such as bone repair biodegradable products that are used in bone regeneration and bone healing, soft tissue regeneration, and muscle connection to bone
Regulatory changes are likely to lead to increased costs relating to new product development and supply of orthobiologics devices. These changes are related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes. The GDPR is an EU law on the data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. Additionally, the FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. In November 2017, the USFDA has announced a comprehensive regenerative medicine policy framework to facilitate innovation. This policy deals with the manufacture of tissues, human cells, and cellular and tissue-based products other procedures to prevent the introduction, transmission, and spread of communicable diseases. Orthobiologics such as stem cell therapies are approved through this framework. The potential loss of revenue due to delays in product release, additional costs incurred by the time-consuming approval processes, and changing regulations puts a strain on investments relating to orthobiologics devices development.
The counties covered in the orthobiologics devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia.
The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).
The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.
The orthobiologics devices and equipment market research report is one of a series of new reports that provides orthobiologics devices and equipment market statistics, including orthobiologics devices and equipment industry global market size, regional shares, competitors with a orthobiologics devices and equipment market share, detailed orthobiologics devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the orthobiologics devices and equipment industry. This orthobiologics devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Major players in the orthobiologics devices and equipment market are Medtronic, Arthrex Inc, DePuy Synthes (A Subsidiary of Johnson & Johnson), Stryker Corporation, Zimmer Biomet, Bioventus LLC, Baxter International Inc, Integra Lifesciences Holding Corporation, Nuvasive INC, and Sanofi.
This product will be delivered within 1-3 business days.
The orthrobiologic devices market consists of sales of demineralized bone matrix, synthetic bone substitutes, stem cell therapy, plasma-rich protein, viscosupplementation, bone morphogenetic protein, and other synthetic orthobiologics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
Orthrobiologic devices are implants composed of cells and proteins that are naturally found in the human body which provide accelerated healing by stimulating efficient regrowth of musculoskeletal tissues including bones, cartilage, tendons, and ligaments.
North America was the largest region in the orthobiologics devices and equipment market in 2022. Western Europe was the second-largest region in the orthobiologics devices and equipment market. The regions covered in orthobiologics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The main product types of orthobiologics devices and equipment are demineralized bone matrix, synthetic bone substitutes, stem cell therapy, plasma-rich protein, viscosupplementation, bone morphogenetic protein, and synthetic orthobiologics. Stem cell therapy is promoting the repair response of diseased, dysfunctional, or injured tissue using stem cells or their derivatives. The various applications involved are osteoarthritis and degenerative arthritis, soft-tissue injuries, fracture recovery, maxillofacial and dental applications, spinal fusion, trauma repair, and reconstructive surgery that are used by various end-users such as hospitals, orthopedic clinics, others.
The aging population profile of most countries contributed to the growth of orthobiologics devices and equipment market globally. According to the United Nations report, there were 962 million people aged over 60 across the globe, comprising 13% of the global population. The population aged over 60 is expected to grow at a rate of about 3% every year. The report further estimated that Europe had the highest percentage of the population aged over 60. The number of people globally over the age of 65 grew by 33%, according to estimates based on Population Reference Bureau data. The increase in the aging population has increased the patient pool of many orthopedic disorders and led to an increase in the demand for orthobiologics devices and equipment market.
Rising incidences of post-surgical complications in patients implanted with orthobiologics devices are one of the major restraints in the orthobiologics devices and equipment market. Surgical procedures with orthobiologics grafts, implants, and devices have become increasingly common in recent years. Major postoperative complications include device failures, bleeding, postoperative infections, immune responses, and rejections. These procedures may develop post-surgery complications which refer to the development of any unwanted or unexpected conditions related to the device, graft, or implant. These complications may vary with the type of procedure, implant, graft, or device, the experience of the surgeon, improper device testing procedures before market launch, device location in the body, and the health and biological response of the individual. The increasing post-operative complications and device failures can limit the orthobiologics devices and equipment market.
Biodegradable implants are increasingly being used in orthobiologics treatment and trauma orthopedic surgeries. Biodegradable implants are used to replace a missing biological structure, support a damaged biological structure, and enhance the existing bone structure. Biodegradable products such as re-absorbable polymers composed of polyglycolic acid and polylactic acid manufactured in the form of plates, screws, and pins are replacing traditional devices like plates and screws which are more expensive. Surgeons are preferring biodegradable implants to replace conventional implants, as biodegradable implants can be engineered to provide temporary support for bone fractures, can degrade at a rate matching new tissue formation, eliminate the need for the second surgery, and are highly useful in fracture fixation in children with less implant-related infections. For instance, Stryker Corp. offers orthobiologics such as bone repair biodegradable products that are used in bone regeneration and bone healing, soft tissue regeneration, and muscle connection to bone
Regulatory changes are likely to lead to increased costs relating to new product development and supply of orthobiologics devices. These changes are related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes. The GDPR is an EU law on the data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. Additionally, the FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. In November 2017, the USFDA has announced a comprehensive regenerative medicine policy framework to facilitate innovation. This policy deals with the manufacture of tissues, human cells, and cellular and tissue-based products other procedures to prevent the introduction, transmission, and spread of communicable diseases. Orthobiologics such as stem cell therapies are approved through this framework. The potential loss of revenue due to delays in product release, additional costs incurred by the time-consuming approval processes, and changing regulations puts a strain on investments relating to orthobiologics devices development.
The counties covered in the orthobiologics devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia.
The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).
The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.
The orthobiologics devices and equipment market research report is one of a series of new reports that provides orthobiologics devices and equipment market statistics, including orthobiologics devices and equipment industry global market size, regional shares, competitors with a orthobiologics devices and equipment market share, detailed orthobiologics devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the orthobiologics devices and equipment industry. This orthobiologics devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Major players in the orthobiologics devices and equipment market are Medtronic, Arthrex Inc, DePuy Synthes (A Subsidiary of Johnson & Johnson), Stryker Corporation, Zimmer Biomet, Bioventus LLC, Baxter International Inc, Integra Lifesciences Holding Corporation, Nuvasive INC, and Sanofi.
This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Orthobiologics Devices and Equipment Market
What is the estimated value of the Global Orthobiologics Devices and Equipment Market?
What is the growth rate of the Global Orthobiologics Devices and Equipment Market?
What is the forecasted size of the Global Orthobiologics Devices and Equipment Market?
Who are the key companies in the Global Orthobiologics Devices and Equipment Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2023 |
| Forecast Period | 2022 - 2026 |
| Estimated Market Value ( USD | $ 4.01 billion |
| Forecasted Market Value ( USD | $ 4.82 billion |
| Compound Annual Growth Rate | 4.7% |
| Regions Covered | Global |
Table of Contents
1. Executive Summary2. Orthobiologics Devices And Equipment Market Characteristics
3. Orthobiologics Devices And Equipment Market Trends And Strategies
4. Orthobiologics Devices And Equipment Market - Macro Economic Scenario
4.1 COVID-19 Impact On Orthobiologics Devices And Equipment Market
4.2 Ukraine-Russia War Impact On Orthobiologics Devices And Equipment Market
4.3 Impact Of High Inflation On Orthobiologics Devices And Equipment Market
5. Orthobiologics Devices And Equipment Market Size And Growth
5.1. Global Orthobiologics Devices And Equipment Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Orthobiologics Devices And Equipment Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Orthobiologics Devices And Equipment Market Segmentation
6.1. Global Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Demineralized Bone Matrix
- Synthetic Bone Substitutes
- Stem Cell Therapy
- Plasma-Rich Protein
- Viscosupplementation
- Bone Morphogenetic Protein
- Synthetic Orthobiologics
- Osteoarthritis and Degenerative Arthritis
- Soft-Tissue Injuries
- Fracture Recovery
- Maxillofacial and Dental Applications
- Spinal Fusion
- Trauma Repair
- Reconstructive Surgery
- Hospitals
- Orthopedic Clinics
- Other End Users
7.1. Global Orthobiologics Devices And Equipment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Orthobiologics Devices And Equipment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Orthobiologics Devices And Equipment Market
8.1. Asia-Pacific Orthobiologics Devices And Equipment Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.3. Asia-Pacific Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.4. Asia-Pacific Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Orthobiologics Devices And Equipment Market
9.1. China Orthobiologics Devices And Equipment Market Overview
9.2. China Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.4. China Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Orthobiologics Devices And Equipment Market
10.1. India Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.3. India Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Orthobiologics Devices And Equipment Market
11.1. Japan Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.3. Japan Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Orthobiologics Devices And Equipment Market
12.1. Australia Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.3. Australia Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Orthobiologics Devices And Equipment Market
13.1. Indonesia Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.3. Indonesia Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Orthobiologics Devices And Equipment Market
14.1. South Korea Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.3. South Korea Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Orthobiologics Devices And Equipment Market
15.1. Western Europe Orthobiologics Devices And Equipment Market Overview
15.2. Western Europe Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.4. Western Europe Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Orthobiologics Devices And Equipment Market
16.1. UK Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.3. UK Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Orthobiologics Devices And Equipment Market
17.1. Germany Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.3. Germany Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Orthobiologics Devices And Equipment Market
18.1. France Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.3. France Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Eastern Europe Orthobiologics Devices And Equipment Market
19.1. Eastern Europe Orthobiologics Devices And Equipment Market Overview
19.2. Eastern Europe Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Eastern Europe Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.4. Eastern Europe Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Russia Orthobiologics Devices And Equipment Market
20.1. Russia Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Russia Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.3. Russia Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. North America Orthobiologics Devices And Equipment Market
21.1. North America Orthobiologics Devices And Equipment Market Overview
21.2. North America Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. North America Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.4. North America Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. USA Orthobiologics Devices And Equipment Market
22.1. USA Orthobiologics Devices And Equipment Market Overview
22.2. USA Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. USA Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.4. USA Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. South America Orthobiologics Devices And Equipment Market
23.1. South America Orthobiologics Devices And Equipment Market Overview
23.2. South America Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. South America Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.4. South America Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. Brazil Orthobiologics Devices And Equipment Market
24.1. Brazil Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.2. Brazil Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.3. Brazil Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Middle East Orthobiologics Devices And Equipment Market
25.1. Middle East Orthobiologics Devices And Equipment Market Overview
25.2. Middle East Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Middle East Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.4. Middle East Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. Africa Orthobiologics Devices And Equipment Market
26.1. Africa Orthobiologics Devices And Equipment Market Overview
26.2. Africa Orthobiologics Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. Africa Orthobiologics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.4. Africa Orthobiologics Devices And Equipment Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Orthobiologics Devices And Equipment Market Competitive Landscape And Company Profiles
27.1. Orthobiologics Devices And Equipment Market Competitive Landscape
27.2. Orthobiologics Devices And Equipment Market Company Profiles
27.2.1. Medtronic
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Arthrex Inc.
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. DePuy Synthes (A Subsidiary of Johnson & Johnson)
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Stryker Corporation
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Zimmer Biomet
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers And Acquisitions In The Orthobiologics Devices And Equipment Market
29. Orthobiologics Devices And Equipment Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Historic And Forecast Inflation Rates
30.4. Research Inquiries
30.5. About the Publisher
30.6. Copyright And Disclaimer
Executive Summary
Orthobiologics Devices And Equipment Global Market Report 2023 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on orthobiologics devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Scope
Markets Covered
1) By Product Type: Demineralized Bone Matrix; Synthetic Bone Substitutes; Stem Cell Therapy; Plasma-Rich Protein; Viscosupplementation; Bone Morphogenetic Protein; Synthetic Orthobiologics2) By Application: Osteoarthritis and Degenerative Arthritis; Soft-Tissue Injuries; Fracture Recovery; Maxillofacial and Dental Applications; Spinal Fusion; Trauma Repair; Reconstructive Surgery
3) By End Use: Hospitals; Orthopedic Clinics; Other End Users
Companies Mentioned: Medtronic; Arthrex Inc.; DePuy Synthes (A Subsidiary of Johnson & Johnson); Stryker Corporation; Zimmer Biomet
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Medtronic
- Arthrex Inc.
- DePuy Synthes (A Subsidiary of Johnson & Johnson)
- Stryker Corporation
- Zimmer Biomet
- Bioventus LLC
- Baxter International Inc.
- Integra Lifesciences Holding Corporation
- Nuvasive INC.
- Sanofi
- Seaspine Holdings Corporation
- Bone Biologics
- Corp.
- Pioneer Surgical Technology
- Smith & Nephew plc
- Osiris Therapeutics, Inc.
- Globus Medical
- Wright Medical Technology
- Orthofix, Inc.
- Harvest Technologies Corporation (A Terumo Bct Company)
- Globus Medical, Inc.
- RTI Surgical Inc.
- K2M Group Holdings Inc.
- Kuros Biosciences Ltd.
- Xtant Medical Holdings Inc.
- Biomet
Methodology
LOADING...
